Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$9.99 - $18.71 $921,887 - $1.73 Million
92,281 New
92,281 $1.71 Million
Q1 2023

May 15, 2023

SELL
$12.53 - $21.71 $1.48 Million - $2.57 Million
-118,507 Reduced 52.47%
107,344 $1.44 Million
Q4 2022

Feb 14, 2023

SELL
$11.61 - $16.11 $1.26 Million - $1.74 Million
-108,317 Reduced 32.41%
225,851 $2.79 Million
Q3 2022

Nov 14, 2022

BUY
$12.21 - $19.7 $3.19 Million - $5.15 Million
261,412 Added 359.3%
334,168 $4.66 Million
Q2 2022

Aug 15, 2022

SELL
$11.23 - $19.59 $1.47 Million - $2.56 Million
-130,495 Reduced 64.2%
72,756 $1.01 Million
Q1 2022

May 16, 2022

BUY
$13.37 - $17.79 $1.19 Million - $1.59 Million
89,247 Added 78.28%
203,251 $3.31 Million
Q4 2021

Feb 14, 2022

BUY
$14.28 - $19.53 $268,178 - $366,773
18,780 Added 19.72%
114,004 $1.86 Million
Q3 2021

Nov 15, 2021

BUY
$12.99 - $20.47 $164,076 - $258,556
12,631 Added 15.29%
95,224 $1.41 Million
Q2 2021

Aug 16, 2021

SELL
$15.46 - $24.5 $558,322 - $884,793
-36,114 Reduced 30.42%
82,593 $1.65 Million
Q1 2021

May 17, 2021

SELL
$19.33 - $37.75 $530,569 - $1.04 Million
-27,448 Reduced 18.78%
118,707 $2.74 Million
Q4 2020

Feb 16, 2021

BUY
$24.48 - $42.47 $2.66 Million - $4.61 Million
108,600 Added 289.18%
146,155 $3.61 Million
Q3 2020

Nov 16, 2020

BUY
$39.09 - $53.44 $984,012 - $1.35 Million
25,173 Added 203.3%
37,555 $1.56 Million
Q2 2020

Aug 14, 2020

SELL
$46.7 - $92.04 $966,082 - $1.9 Million
-20,687 Reduced 62.56%
12,382 $593,000
Q1 2020

May 15, 2020

SELL
$48.35 - $118.68 $1.2 Million - $2.95 Million
-24,842 Reduced 42.9%
33,069 $2.08 Million
Q4 2019

Feb 14, 2020

BUY
$57.36 - $124.1 $1.79 Million - $3.88 Million
31,266 Added 117.34%
57,911 $7.18 Million
Q3 2019

Nov 14, 2019

BUY
$58.69 - $80.46 $1.01 Million - $1.39 Million
17,265 Added 184.06%
26,645 $1.77 Million
Q2 2019

Aug 14, 2019

BUY
$77.77 - $120.68 $729,482 - $1.13 Million
9,380 New
9,380 $746,000
Q1 2019

May 15, 2019

SELL
$91.83 - $120.68 $45,915 - $60,340
-500 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$85.79 - $126.46 $42,895 - $63,230
500 New
500 $50,000
Q2 2018

Aug 14, 2018

SELL
$60.0 - $85.67 $17,160 - $24,501
-286 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$52.72 - $67.25 $179,986 - $229,591
-3,414 Reduced 92.27%
286 $18,000
Q4 2017

Feb 14, 2018

SELL
$58.2 - $72.76 $175,589 - $219,516
-3,017 Reduced 44.92%
3,700 $216,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $382,936 - $797,643
6,717
6,717 $390,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.